Medizinische Universität Graz - Research portal
Navigation/Search
- Researchers
- Institutions
- Projects
- Publications
- Partners
- Sponsors
- Equipment
- Knowhow
- Fields of Research
"Faces" of the day:
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Moser, O; Zaharieva, DP; Adolfsson, P; Battelino, T; Bracken, RM; Buckingham, BA; Danne, T; Davis, EA; Dovč, K; Forlenza, GP; Gillard, P; Hofer, SE; Hovorka, R; Jacobs, PG; Mader, JK; Mathieu, C; Nørgaard, K; Oliver, NS; O'Neal, DN; Pemberton, J; Rabasa-Lhoret, R; Sherr, JL; Sourij, H; Tauschmann, M; Yardley, JE; Riddell, MC.
The use of automated insulin delivery around physical activity and exercise in type 1 diabetes: a position statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD).
Diabetologia. 2025; 68(2):255-280
Doi: 10.1007/s00125-024-06308-z
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
- Moser Othmar
- Co-authors Med Uni Graz
- Mader Julia
- Sourij Harald
- Tauschmann Martin
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Regular physical activity and exercise (PA) are cornerstones of diabetes care for individuals with type 1 diabetes. In recent years, the availability of automated insulin delivery (AID) systems has improved the ability of people with type 1 diabetes to achieve the recommended glucose target ranges. PA provide additional health benefits but can cause glucose fluctuations, which challenges current AID systems. While an increasing number of clinical trials and reviews are being published on different AID systems and PA, it seems prudent at this time to collate this information and develop a position statement on the topic. This joint European Association for the Study of Diabetes (EASD)/International Society for Pediatric and Adolescent Diabetes (ISPAD) position statement reviews current evidence on AID systems and provides detailed clinical practice points for managing PA in children, adolescents and adults with type 1 diabetes using AID technology. It discusses each commercially available AID system individually and provides guidance on their use in PA. Additionally, it addresses different glucose responses to PA and provides stratified therapy options to maintain glucose levels within the target ranges for these age groups.
- Find related publications in this database (using NLM MeSH Indexing)
- Humans - administration & dosage
- Diabetes Mellitus, Type 1 - drug therapy, blood, therapy
- Exercise - physiology
- Insulin Infusion Systems - administration & dosage
- Insulin - therapeutic use, administration & dosage
- Adolescent - administration & dosage
- Child - administration & dosage
- Hypoglycemic Agents - therapeutic use, administration & dosage
- Europe - administration & dosage
- Blood Glucose - metabolism
- Adult - administration & dosage
- Find related publications in this database (Keywords)
- Automated insulin delivery
- CGM
- Exercise
- Glucose
- Insulin pump
- Physical activity
- Position statement
- Type 1 diabetes